[go: up one dir, main page]

IT1392567B1 - USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS - Google Patents

USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS

Info

Publication number
IT1392567B1
IT1392567B1 ITTO2008A000989A ITTO20080989A IT1392567B1 IT 1392567 B1 IT1392567 B1 IT 1392567B1 IT TO2008A000989 A ITTO2008A000989 A IT TO2008A000989A IT TO20080989 A ITTO20080989 A IT TO20080989A IT 1392567 B1 IT1392567 B1 IT 1392567B1
Authority
IT
Italy
Prior art keywords
restoration
alpha
sensitivity
tumor cells
peptide derived
Prior art date
Application number
ITTO2008A000989A
Other languages
Italian (it)
Inventor
Bortoli Michele De
Arianna Panetto
Stefania Reineri
Santina Cutrupi
Original Assignee
Bioindustry Park Del Canavese S P A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioindustry Park Del Canavese S P A filed Critical Bioindustry Park Del Canavese S P A
Priority to ITTO2008A000989A priority Critical patent/IT1392567B1/en
Priority to PCT/EP2009/067932 priority patent/WO2010072843A2/en
Publication of ITTO20080989A1 publication Critical patent/ITTO20080989A1/en
Application granted granted Critical
Publication of IT1392567B1 publication Critical patent/IT1392567B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ITTO2008A000989A 2008-12-24 2008-12-24 USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS IT1392567B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
ITTO2008A000989A IT1392567B1 (en) 2008-12-24 2008-12-24 USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS
PCT/EP2009/067932 WO2010072843A2 (en) 2008-12-24 2009-12-24 Use of a peptide derived from er-alpha for restoring sensitivity to antiestrogenic compounds in breast tumour cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITTO2008A000989A IT1392567B1 (en) 2008-12-24 2008-12-24 USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS

Publications (2)

Publication Number Publication Date
ITTO20080989A1 ITTO20080989A1 (en) 2010-06-25
IT1392567B1 true IT1392567B1 (en) 2012-03-09

Family

ID=41171294

Family Applications (1)

Application Number Title Priority Date Filing Date
ITTO2008A000989A IT1392567B1 (en) 2008-12-24 2008-12-24 USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS

Country Status (2)

Country Link
IT (1) IT1392567B1 (en)
WO (1) WO2010072843A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2717897T3 (en) * 2011-06-13 2017-09-29 The Board Of Trustees Of The University Of Illinois Peptide compositions and methods for treating lung injury, asthma, anaphylaxis, angioedema, systemic vascular permeability syndromes, and nasal congestion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6617162B2 (en) * 2001-12-18 2003-09-09 Isis Pharmaceuticals, Inc. Antisense modulation of estrogen receptor alpha expression
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
SI1940457T1 (en) 2005-10-21 2013-04-30 Catalyst Biosciences, Inc. Modified proteases that inhibit complement activation
WO2007110231A2 (en) 2006-03-28 2007-10-04 Nautilus Biotech, S.A. MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES

Also Published As

Publication number Publication date
WO2010072843A3 (en) 2010-10-07
WO2010072843A2 (en) 2010-07-01
ITTO20080989A1 (en) 2010-06-25

Similar Documents

Publication Publication Date Title
GB2443366B (en) Use of papilla mapping to determine a friction-ridge surface
SMT201900656T1 (en) READY-TO-USE KETOROLAC FORMULATIONS
BRPI0815593A8 (en) tensiometer for use in determining soil capillary potential.
EP2152237A4 (en) NEW PHARMACEUTICAL COMPOSITION
DK2343981T3 (en) GLYPHOSATE FORMULATIONS CONTAINING AMIDOALKYLAMINE TENSIDES
BRPI0910852A2 (en) lipid containing compositions and methods of use thereof
BRPI1013356A8 (en) use of loaded surfactants to reduce tissue stain due to antiperspirants
BRPI0912326A2 (en) water soluble acetaminophen analogs
BRPI0821474A2 (en) stable liquid pharmaceutical formulation
DK2120878T3 (en) Dosage form containing two active pharmaceutical ingredients in different physical forms
EP2344522A4 (en) COMBINING ADJUVANT FORMULATION
DE602008004217D1 (en) PHARMACEUTICAL COMPOSITION
ITFI20090031A1 (en) "MODULAR BLOCK FOR CIVIL WORKS"
BRPI1014914A2 (en) Composition containing trehalulose, its preparation and use
DK1791571T3 (en) Radiofluorinated peptides
HUE036071T2 (en) Therapeutic preparations containing Macitentan
EP2193795A4 (en) LATANOPROSOUS AQUEOUS PHARMACEUTICAL COMPOSITION
UY31758A (en) ORVEPITANT MALEATE ANHYDRA CRYSTAL FORM
ATE480227T1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING QUETIAPINFUMARATE
ZA201104614B (en) Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
ITMI20062254A1 (en) USE OF A METHOXY-ALCANOIC ACID OF THE INZOL TO PREPARE A PHARMACEUTICAL COMPOSITION
IT1392567B1 (en) USE OF A PEPTIDE DERIVED FROM ER-ALPHA FOR THE RESTORATION OF SENSITIVITY TO ANTIESTROGENIC COMPOUNDS IN MAMMARY TUMOR CELLS
EP2156832A4 (en) PHARMACEUTICAL COMPOSITION
ATE486633T1 (en) SOLID PHARMACEUTICAL COMPOSITION CONTAINING TELITHROMYCIN
ITVR20060007U1 (en) DISPENSER DEVICE PREFERIBLY THOUGH BUT NOT LIMITED TO THE COSMETIC AND PHARMACEUTICAL SECTOR